Hypha Labs (FUNI) EBT Margin (2011 - 2024)
Hypha Labs' (FUNI) quarterly EBT Margin came in at 57.46% in Q1 2024, up 2875.0% YoY from 1.93% in Q2 2023, and up 442.47% on a QoQ basis from 16.78% in Q4 2023.
Hypha Labs (FUNI) EBT Margin (2011 - 2024) Analysis & Trends
Hypha Labs (FUNI) has 14 years of EBT Margin data on file, last reported at 57.46% in Q1 2024.
- Quarterly EBT Margin rose 2875.0% year-over-year to 57.46% in Q1 2024, while the trailing twelve-month figure through Sep 2024 was 20.57% (up 8088.0% YoY) and the FY2024 annual result came in at 117.32%, down 7631.0% from the prior year.
- EBT Margin climbed to 57.46% in Q1 2024, from 16.78% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 57.46% in Q1 2024 to a low of 224.32% in Q3 2023.
- A 5-year average of 50.53% and a median of 39.68% in 2021 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2021 — EBT Margin soared 10561 bps — and 2023, when it tumbled 17256 bps.
- Tracing FUNI's EBT Margin over 5 years: stood at 78.07% in 2020, then soared by 49 bps to 39.68% in 2021, then surged by 45 bps to 21.84% in 2022, then grew by 23 bps to 16.78% in 2023, then soared by 442 bps to 57.46% in 2024.
- The last three EBT Margin figures came in at 57.46% (Q1 2024), 16.78% (Q4 2023), and 224.32% (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 16.04% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 17.21% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 34.29% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 22.23% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 6.89% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -12.17% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 22.43% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 28.17% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 13.54% |
| 10 | Hypha Labs | 2.26 Mn | 2.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 57.46% |
| Dec 31, 2023 | -16.78% |
| Sep 30, 2023 | -224.32% |
| Jun 30, 2023 | 38.82% |
| Mar 31, 2023 | 28.71% |
| Dec 31, 2022 | -21.84% |
| Sep 30, 2022 | -51.76% |
| Jun 30, 2022 | -38.49% |
| Mar 31, 2022 | -68.59% |
| Dec 31, 2021 | -39.68% |
| Sep 30, 2021 | -52.76% |
| Jun 30, 2021 | -26.71% |
| Mar 31, 2021 | 2.87% |
| Dec 31, 2020 | -78.07% |
| Sep 30, 2020 | -158.37% |
| Jun 30, 2020 | -126.08% |
| Mar 31, 2020 | -83.46% |
| Dec 31, 2019 | -29.85% |
| Sep 30, 2019 | -58.01% |
| Jun 30, 2019 | -78.02% |